Minorities, specifically blacks and Hispanics, are more than twice as likely to have a second intracerebral hemorrhage than their white counterparts, according to a new …

A research team at Worcester Polytechnic Institute in Massachusetts is engineering functioning human blood vessels which can mimic common cardiac and vascular problems, a tool they hope can be used to test new medications more quickly.…

Almost 3 percent of infants and children hospitalized for pediatric arterial ischemic stroke (AIS) die in the hospital, according to a new international…

Restenosis of the carotid arteries is more likely after stenting than endarterectomy and increases the likelihood of stroke, according to a subanalysis of a randomized trial published in …

Putting some extra pep in your step may prolong your life, according to a study published June 1 in the British Journal of Sports Medicine.

Researchers pooled…

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).

According…

In-home physical therapy using telehealth systems, supervised by a licensed physical therapist, is effective for stroke rehabilitation, according to a study presented May 24 at the 2018 European Stroke Organization Conference in Gothenburg,…

With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May…

Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new …

Human growth hormone showed the potential to improve the memory and cognitive function of mice post-stroke, raising the possibility of a similar treatment for humans.

Mental impairment affects up to 80 percent of stroke…

Individuals with a combination of vascular risk factors and higher levels of beta-amyloid protein in the brain may be on a speedier path of cognitive decline, suggests a…

Senior citizens who reported exercising at least four times a week throughout their lives showed decreased age-related arterial stiffness when compared to more sedentary individuals, according to a…

The FlowTriever System has become the first thrombectomy device designed to treat pulmonary embolism (PE) to be cleared by the FDA, Inari Medical announced in a May 21…

Patients who suffer minor ischemic stroke or a transient ischemic attack (TIA) can lower the risk for a major stroke within 90 days by taking both clopidogrel and aspirin, according to a…

Patients with stroke-related intracerebral hemorrhage (TICH-2), or “bleeding on the brain,” may benefit from receiving tranexamic acid (TXA), a drug used to treat blood loss from trauma and postpartum bleeding…

Researchers at Imperial College London and the University of Edinburgh have developed machine learning software that detects small vessel disease (SVD)—which can ultimately cause stroke.

SVD, as…

Watchman-related thrombi developed in 3.7 percent of patients who were implanted with the device, resulting in a threefold risk of stroke or systemic embolism, according to a meta-analysis of clinical trials and registries…

Atrial fibrillation (AFib) should never be considered fully cured, according to a recent study in The BMJ, because patients with this designation carry higher risks of stroke…

The American Heart Association/American Stroke Association (AHA/ASA), the Paul G. Allen Frontiers Group and other partners are devoting $43 million to fund a research initiative for better ways to prevent and treat age-related cognitive…

Occluding the left atrial appendage with the Watchman device proved to be a cost-effective strategy for the secondary prevention of stroke among patients with atrial fibrillation (AFib), according to an…

A paclitaxel-coated balloon demonstrated significantly higher primary patency rates at 12 months and lower odds of reintervention when compared to uncoated balloon angioplasty for femoropopliteal lesions, according to the first randomized,…